Biologics Consulting
Debra Barngrover is a highly experienced professional in the biopharmaceutical industry, currently serving as Principal Consultant and previously as Senior Consultant at Biologics Consulting since April 2011, specializing in protein, cell therapy, and viral vector process development, among other areas. Prior experience includes a Vice President position at Genzyme for over two decades, and a role as Senior Scientist at Integrated Genetics prior to its merger with Genzyme. Debra began their career as an Ingénieur de Recherches at Elf Biorecherches. Debra holds a Ph.D. in Nutritional Biochemistry and Computer Science from Cornell University.
This person is not in any offices
Biologics Consulting
ABOUT Biologics Consulting is a complete FDA regulatory and product development consulting firm for cell & gene therapy, biologics, pharmaceuticals, and medical devices. In the nearly three decades since its founding, Biologics Consulting has become the go-to consulting partner for companies large and small seeking to bring innovative, safe, and effective products to market in the US. Our team of consultants and professional services staff is comprised of subject-matter experts with decades of industry and/or FDA experience that allows us to provide an unparalleled insider perspective. OUR DIFFERENCE The Biologics Consulting difference is all about the unique combination of expertise we have under one roof. Our team has depth of knowledge and breadth of experience across all product types and development pathways. This value proposition allows us to address the full scope of a client’s regulatory and product development challenges. OUR EXPERIENCE AREAS - Biologics - Medical Devices - Pharmaceuticals - Biosimilars OUR SERVICES - CONSULTING – Regulatory, Product Development, Clinical Planning and Quality support. - SUPPORT SERVICES – Medical Writing, ePublishing & Submissions, US Agent Services, Due Diligence OUR CLIENTS Our clients span the industry, from established multi-national pharmaceutical, biotechnology, and medical device companies to academic and research institutions. We also support small biotech and medical device start-ups. Since our founding, we have professionally services over 4,500 clients from 58 different countries.